SAB Biotherapeutics (SABS) Earnings (2021 - 2026)
SAB Biotherapeutics (SABS) earnings from Mar 31, 2021 to Mar 31, 2026. The TTM SAB Biotherapeutics (SABS) earnings is -$390K. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
SAB Biotherapeutics (SABS) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -98.86% |
| 3 Years TTM | -75.67% |
| All Time TTM | -61.40% |
Annual Earnings change of SAB Biotherapeutics (SABS)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$19M | -242.20% |
| 2025 | $13M | -138.90% |
| 2024 | -$34M | -19.15% |
| 2023 | -$42M | +125.13% |
| 2022 | -$19M | +9.33% |
| 2021 | -$17M | +171300.00% |
| 2020 | -$10K | N/A |